Filing Details
- Accession Number:
- 0001127602-20-011511
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-19 16:50:31
- Reporting Period:
- 2020-03-17
- Accepted Time:
- 2020-03-19 16:50:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1682852 | Moderna Inc. | MRNA | Biological Products, (No Disgnostic Substances) (2836) | 813467528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1760670 | Juan Andres | C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-17 | 16,317 | $12.21 | 16,317 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-03-17 | 10,006 | $30.47 | 6,311 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-17 | 5,581 | $31.98 | 730 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-17 | 730 | $32.50 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-03-18 | 15,281 | $12.21 | 15,281 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-03-18 | 7,094 | $31.06 | 8,187 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-18 | 8,187 | $31.75 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-03-17 | 16,317 | $0.00 | 16,317 | $12.21 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-03-18 | 15,281 | $0.00 | 15,281 | $12.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 890,003 | 2027-08-29 | No | 4 | M | Direct | |
| 874,722 | 2027-08-29 | No | 4 | M | Direct |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.05 to $30.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.40 to $32.40. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.42 to $32.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.40 to $31.40. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.43 to $32.43. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- 25% of this option vested and became exercisable on August 1, 2018 with the remainder vesting in 12 equal quarterly installments thereafter.
Billionaire Hedge Funds
